China Prescription Drug 2009 Issue 1 ai , wo men de xing ye

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

China Prescription Drug
1671-945X
2009 Issue 1

..............page:2

Zhang Boli. The Adverse Reactions of Traditional Chinese Injection is Cognizable and Controllable
mao dong lei ; yang tian

..............page:22

Bioequivalence, the Linchpin in the Approval of Generic Drug
zheng qiang ; li zi li

..............page:46

The Significance and Methods of Bioequivalence Evaluation for Generic Drug in FDA
li bing ; yu zuo qiang

..............page:47

Introduction to Specific Bioequivalence Evaluation
li bing ; yu zuo qiang

..............page:51

Development in the Treatment of Advanced Cancer with Oral Fluorouracils
wang lin ; qin shu zuo

..............page:62

Treatment Choices for Chronic Viral Hepatitis B and Chronic Viral Hepatitis C
lu lun gen

..............page:68

Medicine Treatment Choice for Chronic Viral Hepatitis B
qu ying ; lu lun gen

..............page:69

Drug Resistance of Hepatitis B Virus and Management
zhou zuo ; lu lun gen

..............page:72

Importance of Antiviral Treatment of Hepatitis B-Induced Liver Cirrhosis
zong lei ; lu lun gen

..............page:76

Medicine Treatment for Chronic Viral Hepatitis C
shen lei ; lu lun gen

..............page:78

Clinical Sginificance of Liver Protection Therapy for the Patients with Chronic Virus Hepatitis
zuo xiao chun ; lu lun gen

..............page:82

2008" yao " wen hui gu
bethan;hughes

..............page:8

er tong jiao lv zheng zhi liao de di yi bu
graham;j.;emslie

..............page:10

xin yi dai kang jing shen bing yao wu feng xian zai shou guan zhu
benedict;carey;roni;caryn;rabin

..............page:11

mei yi liao fei yong zhi chu zeng chang shou ci fang huan
robert;pear

..............page:12

biao qian wai yong yao yuan ze ping gu nan ti
yi mu

..............page:13

Clinical Significance of Drug Metabolism Enzyme (DME) Polymorphism
sun zhong shi

..............page:54

Brand Establishment and Expansion in Hospital Marketing
wei jing fa

..............page:56

Drug Package Insert: Legal Basis for Medicine and Proof for Prevention of Drug-induced Sufferings
song ru liang

..............page:58

Marketing Situation of Hypoglycemic Agents in 2008 with the Change of Product Positioning
li zheng ; huang dong lin

..............page:60

xue ye bing hua liao hou kou qiang kui yang de zhi liao

..............page:86

Ren Dequan. Practice, the Sole Criterion for Testing Truth
mao dong lei

..............page:26

Zhou Chaofan. Reevaluation, an Arduous Systems Engineering Project
mao dong lei

..............page:28

Zhu Dayuan. Pharmaceutical Industry Shall Be Responsible to The Society
zuo xue mei

..............page:29

Mainstream Enterprise: The Coming Spring Tide for Safety Reevaluation
zhong zhen hua

..............page:30

Oral History: The Industrialization of Shenqi Fuzheng Injection——from Proved Recipe to SFDA Approved New Drug
zhong zhen hua

..............page:33

The Practice of Digital Traditional Chinese Medicine of Shenqi Fuzheng Injection
pan li

..............page:37

Tao Desheng. The Exploration of the Concept of Digital Traditional Chinese Medicine
zhong zhen hua

..............page:40

Rational Evaluation of the Safety of Traditional Chinese Medicine Injection
yu li

..............page:43